microRNA-196a与肿瘤相关性的研究进展

doi:10.11904/j.issn.1002-3070.2018.01.008

摘要/Abstract

摘要： microRNA-196a(miR-196a)作为miRNA家族中的成员之一,近年来受到了广泛关注。miR-196a不但在多种生物学过程中起重要的调控作用,同时还有研究表明在肿瘤的发生发展中miR-196a还发挥类似癌基因的功能。研究发现,miR-196a在肿瘤患者的血清、组织及细胞中呈高表达,而且能够促进肿瘤细胞增殖、侵袭及转移,抑制肿瘤细胞凋亡,增强肿瘤耐药性。本文结合国内外最新报道对miR-196a与肿瘤相关性研究进展做一综述。

关键词: miR-196a, 肿瘤, microRNA

Abstract: As a member of the miRNA family, microRNA-196a (miR-196a) has received much attention in recent years. MiR-196a not only plays an important regulatory role in various biological processes, but it also shows that miR-196a also functions as oncogene in the tumorigenesis and progression. In recent studies, miR-196a is high expression in the serum, tissues and cells of patients with cancer, and can promote tumor cell proliferation, invasion and metastasis, inhibit tumor cell apoptosis and enhance tumor drug resistance. In this paper, we reviewed the research progress on the correlation between miR-196a and tumor based on the latest reports at domestics and abroad.

Key words: miR-196a, Tumor, microRNA

中图分类号:

R735.3⁺5

辛鹤, 王传卓, 刘兆玉. microRNA-196a与肿瘤相关性的研究进展[J]. 实用肿瘤学杂志, 2018, 32(1): 42-46.

XIN He, WANG Chuanzhuo, LIU Zhaoyu. Research progress on the relationship between microRNA-196a and tumor[J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(1): 42-46.

参考文献

1 Lee RC,Feinbaum RL,Ambros V.et al.Elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14[J].Cell,1993,75(5):843-854.
2 Yekta S,Shih IH,Bartel DP.microRNA-directed cleavage of HOXB8 mRNA[J].Sci,2004,304(5670):594-596.
3 Divoux A,Xie H,Li JL,et al.microRNA-196 regulates HOX gene expression in human gluteal adipose tissue[J].Obesity(Silver Spring),2017,25(8):1375-1383.
4 Arias N,Aguirre L,Fernandez-Quintela A,et al.microRNAs involved in the browning process of adipocytes[J].Physiol Biochem,2016,72(3):509-521.
5 Her LS,Mao SH,Chang CY,et al.MiR-196a enhances neuronal morphology through suppressing RANBP10 to provide neuroprotection in huntington′s disease[J].Theranostics,2017,7(9):2452-2462.
6 Chen F,Chen ZY,Yang HT.Expression profile of microRNAs in the cardiomyocytes derived from mouse embryonic stem cells[J].Sheng Li Xue Bao,2014,66(6):702-708.
7 Qin Y,Wang L,Gao Z,et al.Bone marrow stromal/stem cell-derived extracellular vesicles regulate osteoblast activity and differentiation in vitro and promote bone regeneration in vivo[J].Sci Rep,2016,6:21961.
8 Sehm T,Sachse C,Frenzel C,et al.MiR-196 is an essential early-stage regulator of tail regeneration,upstream of key spinal cord patterning events[J].Dev Biol,2009,334(2):468-480.
9 Calin GA,Sevignani C,Dumitru CD,et al.Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers[J].PNAS,2004,101(101):2999-3004.
10 Debernardi S,Skoulakis S,Molloy G,et al.microRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis[J].Leukemia,2007,21(5):912-916.
11 Shen F,Chen J,Guo S,et al.Genetic variants in miR-196a2 and miR-499 are associated with susceptibility to esophageal squamous cell carcinoma in Chinese Han population[J].Tumour Biol,2016,37(4):4777-4784.
12 吴晓鹏,陈强,刘勤,等.microRNA-196a对食管癌预后的评估价值及其生物学行为的调控机制[J].中国现代医学杂志,2017,27(13):50-57.
13 Luthra R,Singh RR,Luthra MG,et al.microRNA-196a targets annexin A1:a microRNA-mediated mechanism of annexin A1 downregulation in cancers[J].Oncogene,2008,27(52):6667-6678.
14 Wang N,Li Y,Zhou RM,et al.Hsa-miR-196a2 functional SNP is associated with the risk of ESCC in individuals under 60 years old[J].Biomarkers,2014,19(1):43-48.
15 Wang K,Li J,Guo H,et al.MiR-196a binding-site SNP regulates RAP1A expression contributing to esophageal squamous cell carcinoma risk and metastasis[J].Carcinogenesis,2012,33(11):2147-2154.
16 Galardi A,Colletti M,Businaro P,et al.microRNAs in neuroblastoma:biomarkers with therapeutic potential[J].Curr Med Chem,2017[Epub ahead of print].
17 Pan C,Yan X,Li H,et al.Systematic literature review and clinical validation of circulating microRNAs as diagnostic biomarkers for colorectal cancer[J].Oncotarget,2017,8(40):68317-68328.
18 Yu Q,Xu C,Yuan W,et al.Evaluation of plasma microRNAs as diagnostic and prognostic biomarkers in pancreatic adenocarcinoma:miR-196a and miR-210 could be negative and positive prognostic markers,respectively[J].Biomed Res Int,2017,2017:6495867.
19 Hong TH,Park IY.microRNA expression profiling of diagnostic needle aspirates from surgical pancreatic cancer specimens[J].Korean Surg Soc,2014,87(6):290-297.
20 Liu M,Du Y,Gao J,et al.Aberrant expression miR-196a is associated with abnormal apoptosis,invasion,and proliferation of pancreatic cancer cells[J].Pancreas,2013,42(7):1169-1181.
21 Huang F,Tang J,Zhuang X,et al.MiR-196a promotes pancreatic cancer progression by targeting nuclear factor kappa-B-inhibitor alpha[J].PLoS One,2014,9(2):e87897.
22 樊鑫鑫,赵青芳,关露露,等.MiR-196a与ZG16蛋白在结直肠癌中的表达意义及相关性分析[J].中华结直肠疾病电子杂志,2017,6(4):60-62.
23 Nagy ZB,Wichmann B,Kalmar A,et al.Colorectal adenoma and carcinoma specific miRNA profiles in biopsy and their expression in plasma specimens[J].Clin Epigenetics,2017,9:22.
24 Chen X,Du P,She J,et al.Loss of ZG16 is regulated by miR-196a and contributes to stemness and progression of colorectal cancer[J].Oncotarget,2016,7(52):86695-86703.
25 Jacob J,Favicchio R,Karimian N,et al.LMTK3 escapes tumour suppressor miRNAs via sequestration of DDX5[J].Cancer Lett,2016,372(1):137-146.
26 Pan J,Li X,Wu W,et al.Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells[J].Cancer Lett,2016,382(1):64-76.
27 Guo J,Jin M,Zhang M,et al.A genetic variant in miR-196a2 increased digestive system cancer risks:a meta-analysis of 15 case-control studies[J],PLoS One,2012,7(1):e30585.
28 Liu B,Xiang Y,Zhang HS.Circulating microRNA-196a as a candidate diagnostic biomarker for chronic hepatitis C[J].Mol Med Rep,2015,12(1):105-110.
29 Hao Y,Wang J,Zhao L.The effect and mechanism of miR196a in HepG2 cell[J].Biomed Pharmacother,2015,72:1-5.
30 Yang L,Peng F,Qin J,et al.Downregulation of microRNA-196a inhibits human liver cancer cell proliferation and invasion by targeting FOXO1[J].Oncol Rep,2017,38(4):2148-2154.
31 Xu H,Li G,Yue Z,et al.HCV core protein-induced upregulation of microRNA-196a promotes aberrant proliferation in hepatocellular carcinoma by targeting FOXO1[J].Mol Med Rep,2016,13(6):5223-5229.
32 Liu P,Xin F,Ma CF.Clinical significance of serum miR-196a in cervical intraepithelial neoplasia and cervical cancer[J].Genet Mol Res,2015,14(4):17995-8002.
33 Yang W,Hong L,Xu X,et al.LncRNA GAS5 suppresses the tumorigenesis of cervical cancer by downregulating miR-196a and miR-205[J].Tumour Biol,2017,39(7):1010428317711315.
34 Hou T,Ou J,Zhao X,et al.microRNA-196a promotes cervical cancer proliferation through the regulation of FOXO1 and p27Kip1[J].Brit J Cancer,2014,110(5):1260-1268.
35 丁波,王美林,张正东,等.miR-196a2 T＞C基因多态与宫颈癌易感性的关系研究[J].南京医科大学学报,2016,25(1):85-89.
36 Guan Y,Chen L,Bao Y,et al.High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma[J].Int J Exp Pathol,2015,8(6):6576-6588.
37 Yan W,Li R,Liu Y,et al.microRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis[J].Oncotarget,2014,5(24):12908-12915.
38 Guan Y,Mizoguchi M,Yoshimoto K,et al.MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance[J].Clin Cancer Res,2010,16(16):4289-4297.
39 Yang B,Wei ZY,Wang BQ,et al.Down-regulation of the long noncoding RNA-HOX transcript antisense intergenic RNA inhibits the occurrence and progression of glioma[J].J Cell Biochem,2017[Epub ahead of print].
40 Liu C,Lin J,Li L,et al.HPV16 early gene E5 specifically reduces miRNA-196a in cervical cancer cells[J].Sci Rep,2015,5:7653.

[1]	孙力超,杨婧,孙立新,张媛,杨治华,冉宇靓. 采用肝癌球体细胞筛选鉴定识别肝癌干细胞的单抗[J]. 实用肿瘤学杂志, 2019, 33(3): 193-199.
[2]	张佳文,于雁,张薇,曹京燕,罗雯,尚利华. 基于UPLC-TOF/MS的小细胞肺癌患者血清代谢组学研究[J]. 实用肿瘤学杂志, 2019, 33(3): 200-205.
[3]	张茂祥,孙惠昕,宋冰冰. 2008—2012年哈尔滨市道里区恶性肿瘤发病与死亡分析[J]. 实用肿瘤学杂志, 2019, 33(3): 261-265.
[4]	刘乙澍,曲国蕃. 长链非编码RNA在骨肉瘤中的研究进展[J]. 实用肿瘤学杂志, 2019, 33(3): 266-270.
[5]	侯玉雪,李晓莉. Wnt7a与恶性肿瘤的关系及研究进展[J]. 实用肿瘤学杂志, 2019, 33(3): 271-275.
[6]	朱琳,张春霞. 纳米载药系统靶向肿瘤干细胞的研究进展[J]. 实用肿瘤学杂志, 2019, 33(3): 276-279.
[7]	徐晖, 李希, 周春水. 应用以人转录组为靶点的shRNA文库筛选肺癌肿瘤相关抑制基因[J]. 实用肿瘤学杂志, 2019, 33(2): 97-102.
[8]	李诚, 兰莉, 杨超, 张婷婷, 王蕊, 林琳, 田文静. 2015—2017年哈尔滨市恶性肿瘤发病与死亡特征分析[J]. 实用肿瘤学杂志, 2019, 33(1): 62-66.
[9]	丁界先, 张津, 陈永刚, 王兴文综述, 王栓科审校. Wnt信号通路与肿瘤发生的研究进展[J]. 实用肿瘤学杂志, 2019, 33(1): 73-77.
[10]	于芳, 赵培. TRAP1在食管癌发展中的作用及机制研究[J]. 实用肿瘤学杂志, 2018, 32(6): 515-519.
[11]	王亚龙, 吕章艳, 张帆, 冯小双, 魏锣沛, 李鑫, 温艳, 高禹舜, 薛奇, 高树庚, 谭锋维. 人乳头状瘤病毒感染与肺癌预后相关性的Meta分析[J]. 实用肿瘤学杂志, 2018, 32(6): 520-526.
[12]	唐淑丽, 何匡邦, 张纯慧, 程佳楠, 张艳桥. 胃癌组织中miR-320a和CYLD的表达及与临床病理特征及预后的关系[J]. 实用肿瘤学杂志, 2018, 32(6): 538-544.
[13]	阚钧, 周岱翰综述, 张恩欣审校. 肿瘤合并心血管疾病的研究进展[J]. 实用肿瘤学杂志, 2018, 32(6): 558-561.
[14]	顾琦晟综述, 李继坤审校. 锰超氧化物歧化酶在肿瘤发生发展过程中的研究进展[J]. 实用肿瘤学杂志, 2018, 32(6): 562-566.
[15]	刘娟综述, 张澍田审校. 细胞周期蛋白依赖性激酶抑制因子3在肿瘤中的研究进展[J]. 实用肿瘤学杂志, 2018, 32(6): 575-578.